A

Atrys Health SA
MAD:ATRY

Watchlist Manager
Atrys Health SA
MAD:ATRY
Watchlist
Price: 2.92 EUR 0.69% Market Closed
Market Cap: €221.9m

Relative Value

The Relative Value of one ATRY stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.92 EUR, Atrys Health SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATRY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ATRY Competitors Multiples
Atrys Health SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Atrys Health SA
MAD:ATRY
220m EUR 1 -9 8.9 66.1
US
CVS Health Corp
NYSE:CVS
99.7B USD 0.3 212.6 14 14
US
Cigna Corp
NYSE:CI
78.2B USD 0.3 12.7 0 0
US
Cigna Group
XMUN:CGN
63.5B EUR 0.3 12.2 7.8 9.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.9B EUR 1.2 24.3 10.6 16.2
DE
Fresenius Medical Care AG
XMUN:FME
23.9B EUR 1.2 33.1 10.4 22.3
US
Laboratory Corporation of America Holdings
NYSE:LH
23B USD 1.7 26.9 14.4 20.2
US
Quest Diagnostics Inc
NYSE:DGX
21.3B USD 2 22.4 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR 0.6 16.2 6.4 13.7
US
Guardant Health Inc
NASDAQ:GH
12.6B USD 14.1 -31.8 -33.6 -30.5
US
DaVita Inc
NYSE:DVA
10B USD 0.7 12.9 7.3 10
P/E Multiple
Earnings Growth PEG
ES
A
Atrys Health SA
MAD:ATRY
Average P/E: 41.5
Negative Multiple: -9
N/A N/A
US
CVS Health Corp
NYSE:CVS
212.6
32%
6.6
US
Cigna Corp
NYSE:CI
12.7
39%
0.3
US
C
Cigna Group
XMUN:CGN
12.2
39%
0.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
24.3
71%
0.3
DE
Fresenius Medical Care AG
XMUN:FME
33.1
37%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
26.9
30%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
22.4
14%
1.6
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
16.2
37%
0.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -31.8 N/A N/A
US
DaVita Inc
NYSE:DVA
12.9
6%
2.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ES
A
Atrys Health SA
MAD:ATRY
Average EV/EBITDA: 10.2
8.9
7%
1.3
US
CVS Health Corp
NYSE:CVS
14
25%
0.6
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
7.8
4%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.6
14%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
10.4
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
14.4
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
12.2
8%
1.5
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.4
10%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -33.6 N/A N/A
US
DaVita Inc
NYSE:DVA
7.3
4%
1.8